1Petrella S, Ziental-Gelus N, Mayer C, et al. Genetic and struc- tural insights into the dissemination potential of the extremely broad-spectrum class A -lactamase KPC-2 identified in an Escherichia eoli strain and an Enterobacter cloacae strain isola ted from the same patient in France[J]. Antimicrob Agents Chemother, 2008,52 (10) : 3725-3736.
2Samuelsen O,Naseer U,Tofteland S,et al. Emergence of clon- ally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Nor- way and Sweden[J]. J Antimicrob Chemother,2009 ,63 (4) : 654-658.
3Endimiani A, Hujer AM, Perez F, et al. Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA[-J]. J Antimicrob Chemother,2009,63 (3) ..427-437.
4Bratu S,Landman D, Haag R,et al. Rapid spread of carbapen- em-resistant Klebsiella pneumoniae in New York City :a new threat to our antibiotic armamentarium[J]. Arch Intern Med, 2005 ,165 (12) :1430-1435.
5Nordmann P,Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria[J]. Lancet In- fect Dis,2009 ,9 (4) .,228-236.
6Elemam A, Rahimian J, Mandell W. Infection with panresis- tant Klebsiella pneumoniae., a report of 2 cases and a brief re- view of the literature [Jl. Clin Infect Dis, 2009 , 49 (2) : 271- 274.
7Souli M,Galani I,Antoniadou A,et al. An outbreak of infec- tion due to beta-Lactamase Klebsiella pneumoniae Carbapene- mase 2-producing K pneumoniae in a Greek University Hospi- tal: molecular characterization, epidemiology, and outcomes [J]. ClinInfectDis,2010 ,50 (3) :364-373.
8Falagas ME, Maraki S, Karageorgopoulos DE, et al. Antimi- crobial susceptibility of multidrug-resistant (MDR)and exten- sively drug-resistant (XDR)Enterohacteriaceae isolates to fos- fomycin[J]. Int J Antimicrob Agents,2010,35 (3):240-243.
